S21-1011
S21-1011 is a selective inhibitor for butyrylcholinesterase (BChE), with IC50 of 0.059 and 0.162 μM, for eqBChE and hBChE, respectively. S21-1011 exhibits good blood-brain barrier (BBB) permeability and good pharmacokinetic characters. S21-1011 exhibits anti-inflammatory activity through activation of keap1-Nrf2-ARE pathway (EC50 is 23.48 μM for antioxidant element ARE activation), ameliorates cognitive impairment in murine Alzheimer’s disease model[1].
Product Specifications
CAS Number
2671859-87-1
UNSPSC
12352005
Target
Cholinesterase (ChE) ; Keap1-Nrf2
Type
Reference compound
Related Pathways
Neuronal Signaling; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/s21-1011.html
Smiles
CCCC1=CC=C(C(NC2=CN=C(C=CC=C3)C3=C2N4CCN(CC5=CC=CC=C5)CC4)=O)C=C1
Molecular Formula
C30H32N4O
Molecular Weight
464.60
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BChE
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
SIRT1 (Phospho-T530) Conjugated Antibody
SIRT1 (Phospho-T530) Conjugated Antibody
SIRT1 (Phospho-T530) Conjugated Antibody
SIRT1 (Phospho-T530) Conjugated Antibody
SIRT1 (Phospho-T530) Conjugated Antibody